{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:52:33Z","timestamp":1789102353812,"version":"build-2803163510"},"reference-count":34,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T00:00:00Z","timestamp":1680393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Waste of high-cost medicines, such as orphan drugs, is a major problem in healthcare, which leads to excessive costs for treatments. The main objective of this study was to evaluate the impact of a vial-sharing strategy for patisiran, an orphan drug used for the treatment of hereditary transthyretin-mediated amyloidosis, in terms of a reduction in the discarded drug amount and cost savings. The retrospective observational study was conducted in a tertiary referral center (Emilia-Romagna, Italy), between February 2021 and November 2022. Data on drug waste were calculated as \u201c(mg used\u2013mg prescribed)\/mg prescribed\u201d for each session. We found a statistically significant (\u22129.14%, p &lt; 0.001, 95% CI 5.87\u201312.41) absolute difference in mean discarded drug rates per session based on the study phase (before and after vial-sharing introduction) at the two-sample t-test. The absolute difference corresponded to a percentage decrease in the average reduction in the discarded drug rate with vial sharing of 82.96% per session. On an annual scale, the estimated cost savings was EUR 26,203.80\/year for a patient with a standard body weight of 70 kg. In conclusion, we demonstrated that a patisiran vial-sharing program undoubtedly offsets some of the high costs associated with this treatment. We suggest that this easy-to-introduce and cost-effective approach can be applied to the administration of other high-cost drugs.<\/jats:p>","DOI":"10.3390\/healthcare11071013","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T01:37:05Z","timestamp":1680485825000},"page":"1013","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Vial Sharing of High-Cost Drugs to Decrease Leftovers and Costs: A Retrospective Observational Study on Patisiran Administration in Bologna, Italy"],"prefix":"10.3390","volume":"11","author":[{"given":"Margherita","family":"Cozzio","sequence":"first","affiliation":[{"name":"Unit of Hygiene and Medical Statistics, Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy"},{"name":"Unit of Hospital Management, IRCCS Institute of Neurological Sciences of Bologna, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Melis","sequence":"additional","affiliation":[{"name":"Unit of Hygiene and Medical Statistics, Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy"},{"name":"Unit of Hospital Management, IRCCS Institute of Neurological Sciences of Bologna, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-1049","authenticated-orcid":false,"given":"Giusy","family":"La Fauci","sequence":"additional","affiliation":[{"name":"Unit of Hygiene and Medical Statistics, Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy"},{"name":"Unit of Hospital Management, IRCCS Institute of Neurological Sciences of Bologna, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Guaraldi","sequence":"additional","affiliation":[{"name":"Unit of Clinical Neurology NEUROMET, IRCCS Institute of Neurological Sciences of Bologna, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Caputo","sequence":"additional","affiliation":[{"name":"Pharmacy Unit for Cytotoxic Drug Preparations, Bellaria Hospital, Intercompany Pharmaceutical Department, Bologna Local Health Authority, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Lioi","sequence":"additional","affiliation":[{"name":"Pharmacy Unit for Cytotoxic Drug Preparations, Bellaria Hospital, Intercompany Pharmaceutical Department, Bologna Local Health Authority, 40139 Bologna, Italy"},{"name":"IRCCS Institute of Neurological Sciences of Bologna, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Sangiorgi","family":"Cellini","sequence":"additional","affiliation":[{"name":"Pharmacy Unit for Cytotoxic Drug Preparations, Bellaria Hospital, Intercompany Pharmaceutical Department, Bologna Local Health Authority, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Santilli","sequence":"additional","affiliation":[{"name":"Pharmacy Unit for Cytotoxic Drug Preparations, Bellaria Hospital, Intercompany Pharmaceutical Department, Bologna Local Health Authority, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Scarlattei","sequence":"additional","affiliation":[{"name":"Pharmacy Unit for Cytotoxic Drug Preparations, Bellaria Hospital, Intercompany Pharmaceutical Department, Bologna Local Health Authority, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8752-1154","authenticated-orcid":false,"given":"Pasquale","family":"Siravo","sequence":"additional","affiliation":[{"name":"Pharmacy Unit for Cytotoxic Drug Preparations, Bellaria Hospital, Intercompany Pharmaceutical Department, Bologna Local Health Authority, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Zuccheri","sequence":"additional","affiliation":[{"name":"Pharmacy Unit for Cytotoxic Drug Preparations, Bellaria Hospital, Intercompany Pharmaceutical Department, Bologna Local Health Authority, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ziglio","sequence":"additional","affiliation":[{"name":"Unit of Hospital Management, IRCCS Institute of Neurological Sciences of Bologna, 40139 Bologna, Italy"},{"name":"Unit of Hospital Management, Arco and Tione Hospitals, APSS Trento, 38100 Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7276-0277","authenticated-orcid":false,"given":"Marco","family":"Montalti","sequence":"additional","affiliation":[{"name":"Unit of Hygiene and Medical Statistics, Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy"},{"name":"Unit of Hospital Management, IRCCS Institute of Neurological Sciences of Bologna, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,2]]},"reference":[{"key":"ref_1","unstructured":"Bruzzi, S. (2012). Healthcare Regionalisation and Patients Mobility: The Challenges for a Sustainable Italian Health Service, Universit\u00e0 Polo Interregionale di Eccellenza Jean Monnet."},{"key":"ref_2","unstructured":"(2023, March 22). European Observatory on Health Systems and Policies, Italy: Health System Review. Available online: https:\/\/eurohealthobservatory.who.int\/publications\/i\/italy-health-system-review-2022."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s11205-021-02775-8","article-title":"Measuring Regional Performance in the Italian NHS: Are Disparities Decreasing?","volume":"159","author":"Bruzzi","year":"2022","journal-title":"Soc. Indic. Res."},{"key":"ref_4","unstructured":"Ministero della Salute (2023, March 31). Il Finanziamento del Servizio Sanitario Nazionale, Available online: https:\/\/www.salute.gov.it\/portale\/temi\/p2_6.jsp?id=4752&area=programmazioneSanitariaLea&menu=d."},{"key":"ref_5","unstructured":"(2023, January 27). Pharmaceutical Expenditure Tracking, Budgeting and Forecasting in 23 OECD and EU Countries, Organization for Economic Co-operation and Development. Available online: https:\/\/www.oecd.org\/health\/health-systems\/Pharmaceutical-Expenditure-Tracking-Budgeting-Forecasting-Country-Notes.pdf."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Matranga, D., and Maniscalco, L. (2022). Inequality in Healthcare Utilization in Italy: How Important Are Barriers to Access?. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19031697"},{"key":"ref_7","unstructured":"European Medicine Agency (2023, January 27). Orphan Designation: Overview. Available online: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/orphan-designation-overview."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/picr.picr_193_21","article-title":"Advances in Orphan Drug Development: Time to Change the Status and Stereotype","volume":"13","author":"Thakur","year":"2022","journal-title":"Perspect. Clin. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"820757","DOI":"10.3389\/fmed.2022.820757","article-title":"Orphan Drug Prices and Epidemiology of Rare Diseases: A Cross-Sectional Study in Italy in the Years 2014\u20132019","volume":"9","author":"Villa","year":"2022","journal-title":"Front. Med."},{"key":"ref_10","unstructured":"U.S. Food and Drug Administration (2023, March 31). Orphan Drug Act\u2014Relevant Excerpts, Available online: https:\/\/www.fda.gov\/industry\/designating-orphan-product-drugs-and-biological-products\/orphan-drug-act-relevant-excerpts."},{"key":"ref_11","unstructured":"AIFA Agenzia Italiana del F\u00e1rmaco (2023, March 22). L\u2019uso dei Farmaci in Italia: Il Rapporto AIFA, Available online: https:\/\/www.aifa.gov.it\/documents\/20142\/1205984\/rapporto-osmed-2019.pdf\/f41e53a4-710a-7f75-4257-404647d0fe1e."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Gammie, T., Lu, C.Y., and Babar, Z.U.-D. (2015). Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140002"},{"key":"ref_13","unstructured":"Italian Medicines Agency (2023, January 27). Monitoring Pharmaceutical Expenditure, Available online: https:\/\/aifa.gov.it\/monitoraggio-spesa-farmaceutica."},{"key":"ref_14","unstructured":"Welfare Section of the Italian Parliament (2023, January 27). Drugs and Pharmaceutical Expenditure. Available online: https:\/\/temi.camera.it\/leg18\/temi\/tl18_i_farmaci.html."},{"key":"ref_15","unstructured":"Newman, C.N. (2023, January 27). How to Reduce Medicines Waste?. Available online: https:\/\/pharmaceutical-journal.com\/article\/ld\/how-to-reduce-medicines-waste."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/13696998.2018.1467918","article-title":"Drug Wastage and Costs to the Healthcare System in the Care of Patients with Non-Small Cell Lung Cancer in the United States","volume":"21","author":"Hess","year":"2018","journal-title":"J. Med. Econ."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11096-014-9981-2","article-title":"A Systematic Review of the Literature on \u2018Medication Wastage\u2019: An Exploration of Causative Factors and Effect of Interventions","volume":"36","author":"West","year":"2014","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_18","unstructured":"Romero, A. (2013, January 23\u201325). Managing medicines in the hospital pharmacy: Logistics inefficiencies. Proceedings of the World Congress on Engineering and Computer Science, San Francisco, CA, USA."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100400","DOI":"10.1016\/j.scp.2021.100400","article-title":"Waste-Minimising Measures to Achieve Sustainable Supply and Use of Medication","volume":"20","author":"Smale","year":"2021","journal-title":"Sustain. Chem. Pharm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11096-022-01388-6","article-title":"An Economic Evaluation of Vial Sharing of Expensive Drugs in Automated Compounding","volume":"44","author":"Baan","year":"2022","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_21","unstructured":"National Association of Pharmacy Regulatory Authorities (2023, January 27). Model Standards for Pharmacy Compounding of Hazardous Sterile Preparations. Available online: https:\/\/napra.ca\/wp-content\/uploads\/2022\/09\/NAPRA-Mdl-Stnds-Pharmacy-Compounding-Hazardous-Sterile-Preparations-Nov-2016-Revised-b.pdf."},{"key":"ref_22","unstructured":"European Medicines Agency (2023, January 27). Onpattro. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/onpattro."},{"key":"ref_23","unstructured":"Padda, I.S., Mahtani, A.U., and Parmar, M. (2022). StatPearls, StatPearls Publishing."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ejhpharm-2014-000547","article-title":"A 2-Year Retrospective Review of Vial Sharing Options for the Compounding of Cytotoxics","volume":"22","author":"Smith","year":"2015","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_26","unstructured":"StataCorp (2021). Stata Statistical Software: Release 17, StataCorp LLC."},{"key":"ref_27","unstructured":"Poscia, A., Silenzi, A., and Ricciardi, W. (2023, March 31). Italy, Organization and Financing of Public Health Services in Europe: Country Reports, Rechel, B., Maresso, A., Sagan, A., Hernandez-Quevedo, C., Williams, G., Richardson, E., Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507328\/."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/1078155218755867","article-title":"Optimization of Resources by Drug Management: A Multicentred Web-Administered Study on the Use of Ipilimumab in Italy","volume":"25","author":"Damuzzo","year":"2019","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Sodr\u00e9, S.L., Barbosa, I.A.F., Pacheco, I.E., de Queiroz Tavares Ferreira, F., David, M.A., Nascimento, M.A., Arieta, C.E.L., and Cabral de Vasconcellos, J.P. (2019). Costs and Benefits of Bevacizumab Vial Sharing for the Treatment of Retinal Diseases. BMC Public Health, 19.","DOI":"10.1186\/s12889-019-7562-y"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"936686","DOI":"10.3389\/fpubh.2022.936686","article-title":"Cost Analysis of Implementing a Vial-Sharing Strategy for Chemotherapy Drugs Using Intelligent Dispensing Robots in a Tertiary Chinese Hospital in Sichuan","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Public Health"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"i788","DOI":"10.1136\/bmj.i788","article-title":"Overspending Driven by Oversized Single Dose Vials of Cancer Drugs","volume":"352","author":"Bach","year":"2016","journal-title":"BMJ"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1200\/JOP.2017.025411","article-title":"Dose Rounding of Biologic and Cytotoxic Anticancer Agents: A Position Statement of the Hematology\/Oncology Pharmacy Association","volume":"14","author":"Fahrenbruch","year":"2018","journal-title":"J. Oncol. Pract."},{"key":"ref_33","unstructured":"U.S. Food and Drug Administration (2023, January 27). Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products, Available online: https:\/\/www.fda.gov\/files\/drugs\/published\/Allowable-Excess-Volume-and-Labeled-Vial-Fill-Size-in-Injectable-Drug-and-Biological-Products.pdf."},{"key":"ref_34","unstructured":"European Association of Hospital Pharmacists (2023, January 27). Automated Preparation of Oncology Drugs in an Italian Cancer Center: Evaluation of Productivity, Errors Interception, and Waste Reduction Achieved by Managing Vials Overfill. Available online: https:\/\/www.eahp.eu\/gpis\/automated-preparation-oncology-drugs-italian-cancer-center-evaluation-productivity-errors."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/7\/1013\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:08:33Z","timestamp":1760123313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/7\/1013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,2]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["healthcare11071013"],"URL":"https:\/\/doi.org\/10.3390\/healthcare11071013","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,2]]}}}